R

Cartesian Therapeutics
D

RNAC

7.88000
USD
0.45
(6.00%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
204,908,415
المقالات

العنوان: Cartesian Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The companyleverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.